Skip to main content

Syneos Health, Inc.

SYNHDelisted Sep 28, 2023
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001610950

Syneos Health, Inc. was delisted on Sep 28, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 317 institutions reported holding it in 13F filings for Q2 2023, worth $4.32B in total; superinvestors Elliott Investment Management and Southeastern Asset Management (Longleaf) held it.

Holders of 5% or more of SYNH

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Syneos Health, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Syneos Health, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

17 Schedule 13D and 13G filings on Syneos Health, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SYNH
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jun 9, 2023Wellington Management Group LLP13G/AOld format–––SEC
Feb 6, 2023Wellington Management Group LLP13G/AOld format–––SEC
Jan 23, 20233:52 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 10, 2023Vanguard Group Inc13G/AOld format–––SEC
Apr 8, 20229:57 AM ETBlackRock Inc.13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 4, 2022Wellington Management Group LLP13G/AOld format–––SEC
Feb 3, 20224:41 PM ETBlackRock Inc.13G/AOld format–––SEC
Jun 9, 2021Thomas H. Lee Advisors, LLC13D/AOld format–––SEC
Jun 9, 2021Advent International Corp13D/AOld format–––SEC
Jun 9, 2021Wellington Management Group LLP13GOld format–New–SEC
May 11, 2021Thomas H. Lee Advisors, LLC13D/AOld format–––SEC
May 10, 2021Advent International Corp13D/AOld format–––SEC
Mar 5, 2021Advent International Corp13D/AOld format–––SEC
Mar 5, 2021Thomas H. Lee Advisors, LLC13D/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Feb 1, 20218:30 AM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Syneos Health, Inc. shares.

No Form 144 notices for Syneos Health, Inc. are on file.